Zürich27°Overcast
Filtered by Topic
Latest biotech news and updates from Switzerland. AI-curated articles covering biotech topics.
← Show All NewsNovartis
Novartis shares fell sharply after a clinical trial for a muscle-disorder treatment failed, prompting analysts to question confidence in the company’s recently acquired drug pipeline. The setback illustrates the financial and scientific risks behind major pharmaceutical acquisitions.
about 3 hours ago · 1 source
business
Former BeiGene company moves headquarters from Cayman Islands to Basel, reinforcing Switzerland's position as global biotech center
SWI swissinfo.ch
biotech
Chinese companies seek Swiss collaboration amid US tensions, reshaping biotech landscape
SWI swissinfo.ch
business
Basel-based biotech firm BioVersys launches first Swiss IPO of 2025, raising CHF80 million for antibiotic development, with shares starting at CHF36.50 on SIX Swiss Exchange.
SWI swissinfo.ch
business
Swiss pharmaceutical giant Novartis announces closure of recently acquired German biotech firm Morphosys by end of 2025, impacting hundreds of positions.
SWI swissinfo.ch
